Wells Fargo
BTCY

Wells Fargo’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Wells Fargo’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-57
Closed -$84 – 7641
2024
Q1 		$84 Sell
57
-248
-81% -$269 ﹤0.01% 6705
2023
Q4 		$351 Buy
305
+253
+487% +$337 ﹤0.01% 6462
2023
Q3 		$111 Buy
52
+5
+11% +$12 ﹤0.01% 6745
2023
Q2 		$180 Buy
47
+2
+4% +$7 ﹤0.01% 6730
2023
Q1 		$126 Buy
45
+1
+2% +$4 ﹤0.01% 6886
2022
Q4 		$118 Buy
44
+1
+2% +$6 ﹤0.01% 6758
2022
Q3 		$0 Sell
43
-4
-9% -$28 ﹤0.01% 7593
2022
Q2 		$1K Buy
47
+3
+7% +$26 ﹤0.01% 6660
2022
Q1 		$1K Buy
44
+2
+5% +$35 ﹤0.01% 6891
2021
Q4 		$1K Buy
+42
New +$990 ﹤0.01% 7104

Other funds holding BTCY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo's BTCY Position: Q2 2024 in Review

Wells Fargo sold out of Biotricity, Inc. Common Stock (BTCY) in Q2 2024, closing a stake of 57 shares — an estimated $84 sold.

Wells Fargo first reported a position in BTCY in Q4 2021 and held it in 10 quarters. The position peaked at $1K in Q2 2022. 22 funds tracked by Wall St. Rank hold BTCY as of Q2 2024.

  • Wells Fargo reported no remaining Biotricity, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 57 Biotricity, Inc. Common Stock shares in Q2 2024, an estimated $84.
  • Wells Fargo first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Wells Fargo's Biotricity, Inc. Common Stock position peaked at $1K in Q2 2022.
  • 22 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.